Rojo S - Search Results

1

Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.

Rojo S, Wagtmann N, Long EO. Rojo S, et al. Eur J Immunol. 1997 Feb;27(2):568-71. doi: 10.1002/eji.1830270231. Eur J Immunol. 1997. PMID: 9045932

2

Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells.

Rojo S, Burshtyn DN, Long EO, Wagtmann N. Rojo S, et al. J Immunol. 1997 Jan 1;158(1):9-12. J Immunol. 1997. PMID: 8977169

3

Killer cell inhibitory receptors: diversity, specificity, and function.

Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC. Long EO, et al. Among authors: rojo s. Immunol Rev. 1997 Feb;155:135-44. doi: 10.1111/j.1600-065x.1997.tb00946.x. Immunol Rev. 1997. PMID: 9059889 Review.

4

A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors.

Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO. Wagtmann N, et al. Among authors: rojo s. Curr Biol. 1997 Aug 1;7(8):615-8. doi: 10.1016/s0960-9822(06)00263-6. Curr Biol. 1997. PMID: 9259559 Free article. No abstract available.

5

Natural killer cells and mast cells from gp49B null mutant mice are functional.

Rojo S, Stebbins CC, Peterson ME, Dombrowicz D, Wagtmann N, Long EO. Rojo S, et al. Mol Cell Biol. 2000 Oct;20(19):7178-82. doi: 10.1128/MCB.20.19.7178-7182.2000. Mol Cell Biol. 2000. PMID: 10982834 Free PMC article.

6

T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.

Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L, Beck H, McFarland HF, De Mars R, Long EO, Martin R. Vergelli M, et al. Among authors: rojo sc. J Neuroimmunol. 1997 Aug;77(2):195-203. doi: 10.1016/s0165-5728(97)00075-1. J Neuroimmunol. 1997. PMID: 9258250

7

Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.

Aparicio P, Jaraquemada D, Rojo S, López de Castro JA. Aparicio P, et al. Among authors: rojo s. Eur J Immunol. 1988 Feb;18(2):203-9. doi: 10.1002/eji.1830180204. Eur J Immunol. 1988. PMID: 2450755

8

Modulation on immunogenicity by HLA-B27 subtype polymorphism.

Jaraquemada D, Galocha B, Aparicio P, Rojo S, Calvo V, López de Castro JA. Jaraquemada D, et al. Among authors: rojo s. Eur J Immunol. 1988 Dec;18(12):1945-50. doi: 10.1002/eji.1830181212. Eur J Immunol. 1988. PMID: 2464494

9

HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes.

Rojo S, López de Castro JA, Aparicio P, Van Seventer G, Bragado R. Rojo S, et al. J Immunol. 1986 Aug 1;137(3):904-10. J Immunol. 1986. PMID: 2424988

10

Flow cytometric detection of HLA antibodies using a spectrum of microbeads.

Pei R, Lee J, Chen T, Rojo S, Terasaki PI. Pei R, et al. Among authors: rojo s. Hum Immunol. 1999 Dec;60(12):1293-302. doi: 10.1016/s0198-8859(99)00121-4. Hum Immunol. 1999. PMID: 10626745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters